Skip to the page

Data / Form D filings / Cytovia, Inc.

Cytovia, Inc.: Form D filings

Cytovia, Inc., a biotechnology company in Aventura, FL, filed 3 Form D notices with the SEC between 2022 and 2023. The latest, on January 26, 2023, reports $1.2 million sold of a $5 million offering to 10 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
18851 NE 29TH AVENUE, 2ND FLOOR, Aventura, FL, 33180
Phone
(786) 591-7001
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2022
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1936927

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jan 26, 2023New notice$5,000,000$1,195,000$3,805,00010Jan 11, 2023sec.gov
Jul 18, 2022New notice$10,000,000$7,825,000$2,175,00014May 25, 2022sec.gov
Jul 18, 2022New notice$15,000,000$2,525,000$12,475,0009Mar 18, 2022sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Daniel TeperExecutive Officer, Director
Armin RathExecutive Officer
Wei LiExecutive Officer
Michael NoonanExecutive Officer
Gregory FioreDirector
Gilles SeydouxDirector

Other biotechnology companies in Florida that filed recently

Every Form D from the week of Jan 23, 2023 · All recent filings in Florida · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Cytovia, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.